Record Retention Rules in Biotechnology Clinical Trials

Introduction

Record retention rules in biotechnology clinical trials refer to the legal obligations of sponsors, investigators, research institutions and clinical trial organisations to preserve essential documents and research data for a prescribed period. These records include informed consent forms, clinical trial protocols, laboratory reports, case report forms, adverse event reports, investigational product records and regulatory approvals.

Proper record retention is necessary to ensure scientific reliability, participant safety, regulatory accountability and protection against research misconduct. In biotechnology, records may also contain sensitive genetic information and biological data, making confidentiality and secure storage essential.

In India, clinical trial record retention is primarily governed by the New Drugs and Clinical Trials Rules, 2019, the Drugs and Cosmetics Rules, 1945, and applicable ethical guidelines.

Legal Framework

1. New Drugs and Clinical Trials Rules, 2019

The New Drugs and Clinical Trials Rules, 2019, framed under the Drugs and Cosmetics Act, 1940, prescribe record-maintenance obligations for clinical trials and related research.

Rule 13 requires Ethics Committees to preserve trial-related records for five years after completion of the clinical trial. These include protocols, case report forms, meeting minutes, final reports, adverse-event records and compensation-related documents.

CDSCO+1

The 2024 amendment also strengthened documentation requirements for Clinical Research Organisations (CROs). CROs must maintain complete and accurate records, including electronic and other digital formats, for five years after study completion or at least two years after expiry of the relevant drug batch, whichever is later.

ClinRegs

2. ICMR Ethical Guidelines

The ICMR National Ethical Guidelines, 2017, require Ethics Committees to preserve records for at least three years after study completion or termination. Regulatory clinical trial documents must generally be archived for five years or as required by applicable regulations. Longer retention may be necessary where sponsors or regulatory authorities prescribe it.

NCDIR India

Important Case Laws

1. Swasthya Adhikar Manch v. Union of India (2013)

The Supreme Court examined allegations of irregularities in clinical trials and the protection of trial participants. The Court accepted the requirement that audiovisual recordings of informed consent and related documentation must be preserved while maintaining confidentiality.

The decision is significant because it connects clinical trial documentation with participant protection, transparency and regulatory accountability. It supports the principle that research records must remain available for verification.

SpotLaw+1

2. Jacob Puliyel v. Union of India (2022)

The Supreme Court examined the regulatory framework governing COVID-19 vaccines and clinical trial requirements. It referred to the New Drugs and Clinical Trials Rules, 2019, and emphasised compliance with statutory requirements concerning clinical trial conduct, safety, reporting and documentation.

The judgment reinforces the importance of maintaining reliable clinical trial records for regulatory supervision and public accountability.

Sci API+1

Conclusion

Record retention is a fundamental requirement of biotechnology clinical research. Indian law requires research organisations, sponsors, investigators and Ethics Committees to preserve accurate, complete and confidential records for prescribed periods. The New Drugs and Clinical Trials Rules, 2019, and ICMR guidelines establish the principal framework for clinical trial documentation. Judicial decisions in Swasthya Adhikar Manch and Jacob Puliyel reinforce the importance of reliable records, participant protection and regulatory accountability. Therefore, records must not be destroyed before the applicable retention period expires, particularly where investigations, compensation claims or regulatory proceedings remain pending.